Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial
- PMID: 27538259
- DOI: 10.7326/M16-0513
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial
Abstract
Background: Whether vaccinating children with intranasal live attenuated influenza vaccine (LAIV) is more effective than inactivated influenza vaccine (IIV) in providing both direct protection in vaccinated persons and herd protection in unvaccinated persons is uncertain. Hutterite colonies, where members live in close-knit, small rural communities in which influenza virus infection regularly occurs, offer an opportunity to address this question.
Objective: To determine whether vaccinating children and adolescents with LAIV provides better community protection than IIV.
Design: A cluster randomized blinded trial conducted between October 2012 and May 2015 over 3 influenza seasons. (ClinicalTrials.gov: NCT01653015).
Setting: 52 Hutterite colonies in Alberta and Saskatchewan, Canada.
Participants: 1186 Canadian children and adolescents aged 36 months to 15 years who received the study vaccine and 3425 community members who did not.
Intervention: Children were randomly assigned according to community in a blinded manner to receive standard dosing of either trivalent LAIV or trivalent IIV.
Measurements: The primary outcome was reverse transcriptase polymerase chain reaction-confirmed influenza A or B virus in all participants (vaccinated children and persons who did not receive the study vaccine).
Results: Mean vaccine coverage among children in the LAIV group was 76.9% versus 72.3% in the IIV group. Influenza virus infection occurred at a rate of 5.3% (295 of 5560 person-years) in the LAIV group versus 5.2% (304 of 5810 person-years) in the IIV group. The hazard ratio comparing LAIV with IIV for influenza A or B virus was 1.03 (95% CI, 0.85 to 1.24).
Limitation: The study was conducted in Hutterite communities, which may limit generalizability.
Conclusion: Immunizing children with LAIV does not provide better community protection against influenza than IIV.
Primary funding source: The Canadian Institutes for Health Research.
Similar articles
-
Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.JAMA Pediatr. 2018 Sep 1;172(9):e181514. doi: 10.1001/jamapediatrics.2018.1514. Epub 2018 Sep 4. JAMA Pediatr. 2018. PMID: 29971427 Free PMC article.
-
Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.Vaccine. 2015 Sep 11;33(38):4910-5. doi: 10.1016/j.vaccine.2015.07.044. Epub 2015 Jul 29. Vaccine. 2015. PMID: 26232348 Clinical Trial.
-
Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.JAMA. 2010 Mar 10;303(10):943-50. doi: 10.1001/jama.2010.250. JAMA. 2010. PMID: 20215608 Clinical Trial.
-
[Advantages and disadvantages of inactivated and live influenza vaccine].Vopr Virusol. 2004 Jul-Aug;49(4):4-12. Vopr Virusol. 2004. PMID: 15293504 Review. Russian.
-
Vaccinating high-risk children with the intranasal live-attenuated influenza vaccine: the Quebec experience.Paediatr Respir Rev. 2014 Dec;15(4):340-7. doi: 10.1016/j.prrv.2014.06.002. Epub 2014 Jun 28. Paediatr Respir Rev. 2014. PMID: 25242731 Review.
Cited by
-
Head-to-head comparison of influenza vaccines in children: a systematic review and meta-analysis.J Transl Med. 2024 Oct 4;22(1):903. doi: 10.1186/s12967-024-05676-9. J Transl Med. 2024. PMID: 39367499 Free PMC article.
-
Leveraging Contact Network Information in Clustered Randomized Studies of Contagion Processes.Obs Stud. 2023;9(2):157-175. doi: 10.1353/obs.2023.0021. Obs Stud. 2023. PMID: 37325081 Free PMC article.
-
Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children.Cell Rep Med. 2022 Feb 3;3(2):100509. doi: 10.1016/j.xcrm.2022.100509. eCollection 2022 Feb 15. Cell Rep Med. 2022. PMID: 35243417 Free PMC article.
-
[Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].J Prev Med Hyg. 2021 Sep 10;62(2 Suppl 1):E1-E118. doi: 10.15167/2421-4248/jpmh2021.62.2s1. eCollection 2021 Jun. J Prev Med Hyg. 2021. PMID: 34909481 Free PMC article. Italian. No abstract available.
-
Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine.Can Commun Dis Rep. 2021 Jun 9;47(56):279-284. doi: 10.14745/ccdr.v47i56a06. eCollection 2021 Jun 9. Can Commun Dis Rep. 2021. PMID: 34220353 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical